EANO-EURACAN-SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors

R Rudà, D Capper, AD Waldman, J Pallud… - Neuro …, 2022 - academic.oup.com
In the new WHO 2021 Classification of CNS Tumors the chapter “Circumscribed astrocytic
gliomas, glioneuronal and neuronal tumors” encompasses several different rare tumor …

[HTML][HTML] Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations

H Northrup, ME Aronow, EM Bebin, J Bissler… - Pediatric Neurology, 2021 - Elsevier
Background Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …

[HTML][HTML] Tuberous sclerosis complex for the pulmonologist

Y Rebaine, M Nasser, B Girerd… - European Respiratory …, 2021 - Eur Respiratory Soc
Tuberous sclerosis complex (TSC) is a rare multisystem genetic disorder affecting almost all
organs with no sex predominance. TSC has an autosomal-dominant inheritance and is …

Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA)

D Ebrahimi-Fakhari, DN Franz - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Subependymal ependymal giant cell astrocytomas (SEGAs) occur almost
exclusively in the setting of tuberous sclerosis (TSC). They are low-grade gliomas which …

[HTML][HTML] Tsc2 coordinates neuroprogenitor differentiation

VA Riley, V Shankar, JC Holmberg, AM Sokolov… - Iscience, 2023 - cell.com
Neural stem cells (NSCs) of the ventricular-subventricular zone (V-SVZ) generate numerous
cell types. The uncoupling of mRNA transcript availability and translation occurs during the …

[HTML][HTML] Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis–Final Results From the EMINENTS …

K Bobeff, K Krajewska, D Baranska, K Kotulska… - Frontiers in …, 2021 - frontiersin.org
The aim of this EMINENTS prospective, single-center, open-label, single-arm study was to
evaluate the cumulative efficacy and safety of reduced doses of everolimus (maintenance …

[HTML][HTML] Nervous system (NS) tumors in cancer predisposition syndromes

P Patil, BB Pencheva, VM Patil, J Fangusaro - Neurotherapeutics, 2022 - Elsevier
Genetic syndromes which develop one or more nervous system (NS) tumors as one of the
manifestations can be grouped under the umbrella term of NS tumor predisposition …

Neuroimaging in tuberous sclerosis complex

C Russo, A Nastro, D Cicala, M De Liso… - Child's Nervous …, 2020 - Springer
Introduction Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder
affecting multiple systems, due to inactivating mutations of TSC1 or TSC2 mTOR pathway …

[HTML][HTML] Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex—Current Views on Their Pathogenesis and Management

C Gao, B Zabielska, F Jiao, D Mei, X Wang… - Journal of clinical …, 2023 - mdpi.com
Introduction, Tuberous sclerosis complex (TSC) is an autosomal-dominant disorder caused
by mutations inactivating TSC1 or TSC2 genes and characterized by the presence of tumors …

Subependymal giant-cell astrocytoma: A surgical review in the modern era of mTOR inhibitors

G Danassegarane, J Tinois, Y Sahler, S Aouaissia… - Neurochirurgie, 2022 - Elsevier
Introduction Surgical removal has been the historical treatment for subependymal giant-cell
astrocytoma (SEGA) in tuberous sclerosis complex (TSC) patients. In the past decade …